The Clinical Outcome of Prospective Screening for Multiple Endocrine Neoplasia Type 2A
Robert F. Gagel(The University of Texas MD Anderson Cancer Center), Seymour Reichlin, A H Tashjian(Harvard University), T.S. Cummings, Hubert J. Wolfe(Tufts University), N. PAPATHANASOPOULOS, Ronald A. DeLellis(Providence College)
Cited by 330
Related Papers
Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
|Journal of Clinical Oncology|2011|551
Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
|Journal of Clinical Oncology|2010|517
C-Cell Hyperplasia Preceding Medullary Thyroid Carcinoma
|New England Journal of Medicine|1973|452
Production of cytokines around loosened cemented acetabular components. Analysis with immunohistochemical techniques and in situ hybridization.
|Journal of Bone and Joint Surgery|1993|437